Form 4: Mesa Laboratories Inc /Co/ Director Reports Stock Transactio
Insider Transaction (Form 4)
Mark Christopher Capone, a Director of Mesa Laboratories Inc /Co/, reported multiple transactions in common stock on August 15, 2026.
Summary
- Option exercise/conversion: acquired 2,784 Common Stock on August 15, 2026; holds 6,213 after (Direct).
- Option exercise/conversion: disposed of 2,784 Restricted Stock Units - 3 on August 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Christopher Capone — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Option exercise/conversion | Common Stock | 2,784 | — | — | 6,213 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units - 3 | 2,784 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Option exercise/conversion (2,784 shares) |
| 2026-08-15 | Option exercise/conversion (2,784 shares) |
Keywords
insider transaction, Form 4, MLAB, MESA LABORATORIES INC /CO/, neutral, Mark Christopher Capone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.